FERRIC CITRATE

Post-LOE

ferric citrate

Teva

ANDAORALTABLET

Approved

Mar 2026

Lifecycle

Post-LOE

Competitive Pressure

30/100

Clinical Trials

Data completeness

4/8 — Partial

FERRIC CITRATE (ferric citrate) by Teva is phosphate. Approved for iron deficiency anemia in adult patients with chronic kidney disease not on dialysis. First approved in 2026.

Drug data last refreshed 1w ago

Mechanism of Action

phosphate. This compound is insoluble and is excreted in the stool. By binding phosphate in the GI tract and decreasing absorption, ferric citrate lowers the phosphate concentration in the serum. Iron Deficiency Anemia in Chronic Kidney Disease Not on Dialysis Ferric iron is reduced from the ferric…

Indications (1)

iron deficiency anemia in adult patients with chronic kidney disease not on dialysis

Clinical Trials (6)

NCT04741646Phase 2Recruiting

Ferric Citrate and Chronic Kidney Disease in Children

Started Jun 2022

160 enrolled

Chronic Kidney Diseases

NCT05085275Phase 3Completed

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Started Mar 2022

289 enrolled

Anemia, Iron DeficiencyHyperphosphatemiaRenal Insufficiency, Chronic+4 more

NCT04922645Phase 4Completed

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

Started Jun 2021

214 enrolled

HyperphosphatemiaAnemia, Iron DeficiencyRenal Insufficiency

NCT04543812Phase 3Completed

PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD

Started Oct 2020

141 enrolled

Anemia of Chronic Kidney Disease

NCT03984760Phase 3Completed

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

Started Jun 2019

240 enrolled

HyperphosphatemiaEnd Stage Renal DiseaseESRD

Worked on FERRIC CITRATE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.